-
公开(公告)号:EP4455147A1
公开(公告)日:2024-10-30
申请号:EP22910205.8
申请日:2022-12-23
发明人: ZHOU, Fusheng , ZHAO, Jinzhu , CAO, Yudong , XIONG, Lun , SHI, Rongzhen , LAN, Jiong
IPC分类号: C07D487/22 , A61K31/4985 , A61P35/00
摘要: Provided are a polymorph of a KRAS inhibitor, a preparation method therefor, and a use thereof. Specifically disclosed is a pharmaceutically acceptable salt of a compound 1 or a polymorph of the compound or pharmaceutically acceptable salt thereof, and further disclosed are a preparation method for the salt or polymorph and an application of the salt or polymorph in the treatment and/or prevention of KRAS G12C mutation-related diseases.
-
2.
公开(公告)号:EP3651588B1
公开(公告)日:2024-03-13
申请号:EP18753277.5
申请日:2018-07-10
-
3.
公开(公告)号:EP4319823A1
公开(公告)日:2024-02-14
申请号:EP22785440.3
申请日:2022-04-07
发明人: LINDSEY, Jonathan S. , MACNEVIN, Christopher , AKHIGBE, Joshua , GORCZYNSKI, Michael , TANIGUCHI, Masahiko
IPC分类号: A61K49/00 , C07D487/22
-
公开(公告)号:EP4132939B1
公开(公告)日:2024-01-31
申请号:EP21715289.1
申请日:2021-04-01
发明人: STOESSEL, Philipp
IPC分类号: H10K85/30 , C07F5/02 , C07F7/08 , C07F9/6584 , C07D471/22 , C07D487/22 , C07D513/22 , C07F9/6564 , H10K85/60
-
5.
公开(公告)号:EP3340983B1
公开(公告)日:2023-10-04
申请号:EP16840165.1
申请日:2016-08-25
发明人: WILES, Jason, Allan , PHADKE, Avinash, S. , DESHPANDE, Milind , AGARWAL, Atul , CHEN, Dawei , GADHACHANDA, Venkat, Rao , HASHIMOTO, Akihiro , PAIS, Godwin , WANG, Qiuping , WANG, Xiangzhu , GREENLEE, William
IPC分类号: C07D487/04 , C07D487/22 , C07D493/04 , C07D403/12 , C07D401/14 , C07D405/14 , C07D413/14 , C07F9/6558 , C07D403/04 , C07D403/10 , C07D417/14 , C07D471/04 , C07D513/04 , C07D519/00 , A61P29/00 , A61P37/00 , C07D403/14 , C07D407/14 , C07D409/14 , A61P1/16
-
公开(公告)号:EP4201937A1
公开(公告)日:2023-06-28
申请号:EP21857691.6
申请日:2021-08-18
发明人: ZHAO, Weijie , SU, Jiang'an , LI, Qing , WANG, Xiaohuai , SHAO, Kun , YU, Bo , WANG, Xiaqing
IPC分类号: C07D487/22 , A61K41/00 , A61P35/00 , A61P35/04
摘要: The present invention relates to a chlorin derivative or a pharmaceutically acceptable salt thereof, a preparation method thereof, an anti-tumor composition including the chlorin derivative or the pharmaceutically acceptable salt thereof, use of the chlorin derivative or the pharmaceutically acceptable salt thereof in the manufacture of an anti-tumor drug, and a combination of the chlorin derivative or the pharmaceutically acceptable salt thereof and an ultrasound medical system. The chlorin derivative or the pharmaceutically acceptable salt thereof has a structure represented by formula (I), and the ultrasonic medical system comprises a transducer ultrasonic bed and a contact agent. The chlorin derivative of the present invention can be used in photodynamic therapy and sonodynamic therapy, thereby effectively inhibiting and treating cancer.
-
公开(公告)号:EP4172252A1
公开(公告)日:2023-05-03
申请号:EP21734365.6
申请日:2021-06-29
IPC分类号: C08J7/16 , C07D487/22 , C08G12/26
-
公开(公告)号:EP4157907A1
公开(公告)日:2023-04-05
申请号:EP21732586.9
申请日:2021-06-01
申请人: Bio-Fence Ltd.
发明人: HITRIK, Maria
IPC分类号: C08G12/32 , C08G12/38 , C08L61/28 , C08L61/30 , C09D161/28 , C09D161/30 , C07D251/64 , C07D487/22
-
公开(公告)号:EP4101506A1
公开(公告)日:2022-12-14
申请号:EP21750642.7
申请日:2021-02-04
发明人: KANAI Motomu , YAMATSUGU Kenzo , TATSUMI Toshifumi , TAKAHASHI Kazuki , KODAMA Tatsuhiko , SUGIYAMA Akira , TSUKAGOSHI Masanobu , TODA Yuzo
IPC分类号: A61P35/00 , C09B47/30 , C07K16/28 , C07F7/10 , C07D487/22 , A61K47/55 , A61K47/64 , A61K47/68 , A61K41/00 , A61K31/695
摘要: Objects of the present invention are to provide a novel phthalocyanine dye for use in photoimmunotherapy, and a method for producing the same, and to provide a conjugate of the above-described phthalocyanine dye and an antibody or a peptide. According to the present invention, a compound represented by the following formula (1) or a salt thereof is provided:
wherein X represents a substituent having a hydrophilic group at the terminus thereof; L 3 , L 4 , L 5 , and L 6 each independently represent a divalent linking group; Y represents a group capable of binding to an antibody or a peptide; R 3 represents a substituent, such as an alkyl group containing 1 to 6 carbon atoms, an alkoxy group containing 1 to 6 carbon atoms, a halogen atom, -SR 11 , -SOR 12 , an aryl group containing 6 to 10 carbon atoms, -N(R 13 )(R 14 ), or -NO 2 , wherein when a plurality of R 3 s are present, the plurality of R 3 s may be identical to or different from one another; and s represents an integer of 0 to 4.-
公开(公告)号:EP4032885A1
公开(公告)日:2022-07-27
申请号:EP22159533.3
申请日:2017-04-05
发明人: CHARNLEY, Adam Kenneth , DARCY, Michael G. , DODSON, Jason W. , DONG, Xiaoyang , HUGHES, Terry V. , KANG, Jianxing , LEISTER, Lara Kathryn , LIAN, Yiqian , LI, Yue , MEHLMANN, John F. , NEVINS, Neysa , RAMANJULU, Joshi M. , ROMANO, Joseph J. , WANG, Gren Z. , YE, Guosen , ZHANG, Daohua
IPC分类号: C07D405/14 , C07D413/14 , C07D403/14 , C07D487/22 , C07D493/10 , C07D498/18 , C07F9/09 , A61K31/4184 , A61P31/08 , A61P35/00 , A61P37/00
摘要: Disclosed are compounds having the formula:
wherein q, r, s, A, B, C, R A1 , R A2 , R B1 , R B2 , R C1 , R C2 , R 3 , R 4 , R 5 , R 6 , R 14 , R 15 , R 16 , and R 17 , are as defined herein, or a tautomer thereof, or a salt, particularly a pharmaceutically acceptable salt, thereof.
-
-
-
-
-
-
-
-
-